ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

INUV vs HAO // EV/EBITDA & P/E VALUATION

Inuvo Inc. (NYSE) VS. Haoxi Health Technology Limited (Class A) (NASDAQ) • 15-METRIC TALLY: INUV 3 — HAO 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INUV VS. HAO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC INUV HAO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 74.50% 96.00% -21.50 HAO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -24.98% — — TIE /fcf-yield <GO>
Operating Margin -7.80% -60.00% +52.20 INUV /operating-margins <GO>
Net Profit Margin -5.90% 68.00% -73.90 HAO /net-margins <GO>
Revenue Growth (YoY) 2.90% -54.60% +57.50 INUV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.9 34.0 -3.05 HAO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $7.2M $1.3M $5.9M INUV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR INUV REV HAO REV INUV GROSS % HAO GROSS % INUV FCF HAO FCF
FY 2025 $86.2M $537.6K 74.5% 98.0% -$1.8M -$3.4M
FY 2024 $83.8M $1.2M 85.6% 98.0% $229.6K -$802.9K
FY 2023 $0 $28.2M — — -$2.6M -$872.1K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INUV // BETA —
HAO // BETA —